Search

M2 PRESSWIRE-November 29, 2023-: Primary Myelofibrosis Market to Show a Rise During the Forecast Period, Asserts DelveInsight | Companies - Teva Pharmaceutical, Pfizer, Roche, Novartis (C)1994-2023 M2 COMMUNICATIONS RDATE:28112023 DelveInsight's [...]

M2 PRESSWIRE-November 29, 2023-: Chiari Malformation Market to Show a Rise During the Forecast Period, asserts DelveInsight | Companies - Roche, Pfizer, Novartis (C)1994-2023 M2 COMMUNICATIONS RDATE:28112023 DelveInsight's 'Chiari Malformation- [...]

M2 PRESSWIRE-November 24, 2023-: Estimating the CAGR of 12.24%: Global Active Pharmaceutical Ingredient Market Projections till 2028, DelveInsight Analytics | Sun Pharma, Merck, Teva Pharma, Pfizer, Novartis, Boehringer Ingelheim (C)1994-2023 [...]

M2 PRESSWIRE-November 24, 2023-: KRAS Inhibitors Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Novartis, Roche, Eli Lilly, Verastem Oncology, Boehringer Ingelheim, Revolution (C)1994-2023 [...]

M2 PRESSWIRE-November 23, 2023-: Exploring Accelerated Growth Potential in the Alzheimer's Disease Market from 2023 to 2032: A DelveInsight Analysis Covering Sanofi, Novartis, BioVie, AB Science, Eli Lilly, Cassava Science [...]

M2 PRESSWIRE-November 23, 2023-: CNS Lymphoma Market to Show a Rise During the Study Period, estimates DelveInsight | Companies - Eli Lilly and Company, Janssen, Bristol-Myers Squibb, Novartis, Turning Point [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: B-cell lymphoma is a diverse group of blood cancers that originate from abnormal B lymphocytes, a type of [...]

B-cell lymphoma, a subtype of non-Hodgkin lymphoma, stands as the leading cancer diagnosis in the United States, comprising 85% of all cases. This cancer targets the lymphatic system, encompassing lymph [...]

NEW YORK, Nov. 20, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/ewings-sarcoma-treatment-market-industry-size-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk47_2023_016_rep&utm_content=IRTNTR72933 size is expected to grow byUSD 205.09 million from 2023 to 2028. In addition, the momentum of the market will progress at [...]

M2 PRESSWIRE-November 17, 2023-: Gene Therapy Research Report 2023: Market Analysis by Gene Silencing, Gene Augmentation, Vector, Therapeutic Area, Delivery Method, RoA - Global Forecast to 2028 (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-November 16, 2023-: Lupus Nephritis Market to Expand at a Significant Growth Rate During the Forecast Period (2023-32) - Estimates DelveInsight | Roche, Equillium, Argenx, AstraZeneca, Novartis, RemeGen, Annexon [...]

NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The https://www.technavio.com/report/precision-medicine-market-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_vrd_wk46_2023_021_rep&utm_content=IRTNTR75258 size is expected to grow by54.7 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Pune, India: The Insight Partners has issued the following news release: Epilepsy is a neurological condition that can cause seizures and affects millions of people globally. Epilepsy drugs are also [...]

NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/anti-cd20-monoclonal-antibodies-mabs-market-size-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_VRD_wk45_2023_019_rep&utm_content=IRTNTR71141 is expected to grow byUSD 11.42 billion from 2023 to 2028. In addition, the momentum of the market will progress at aCAGR [...]

(GlobeNewswire) - Epilepsy is a neurological condition that can cause seizures and affects millions of people globally. Epilepsy drugs are also known as anti-epileptic drugs (AEDs), which are commonly used [...]

M2 PRESSWIRE-November 7, 2023-: Homozygous Familial Hypercholesterolemia Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Amryt Pharma, Novartis, Ultragenyx Pharma, Arrowhead (C)1994-2023 M2 COMMUNICATIONS [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Sarcoidosis Market Insights report includes a comprehensive understanding of current treatment practices, sarcoidosis emerging drugs, market share [...]

NEWARK: Future Market Insights Global and Consulting Pvt. Ltd. has issued the following news release: The vision care market in North America is anticipated to expand at a CAGR of [...]

Wilmington, Delaware, United States, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ovarian cancer treatment market was estimated to have acquired US$ 5.1 billion in [...]

M2 PHARMA-February 28, 2024-Langerhans Cell Histiocytosis Market and Epidemiology Report 2032, by DelveInsight | Adimab, Innovent Biologics, Affimed, Novartis, Amgen, AstraZeneca, Sanofi, Roche, Regeneron, Eli Lilly (C)2024 M2 COMMUNICATIONS 'Langerhans [...]

M2 EQUITYBITES-February 28, 2024-Langerhans Cell Histiocytosis Market and Epidemiology Report 2032, by DelveInsight | Adimab, Innovent Biologics, Affimed, Novartis, Amgen, AstraZeneca, Sanofi, Roche, Regeneron, Eli Lilly (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk [...]

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- The https://www.technavio.com/report/epidermal-growth-factor-receptor-egfr-inhibitors-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_sv_wk44_2023_021_rep&utm_content=IRTNTR72701 size is expected to grow byUSD 8.39 billion from 2023 to 2028. In addition, the momentum of the market will progress [...]

NEW YORK: Technavio has issued the following news release: The Biosimilars Market size is forecast to grow by USD 42.22 billion between 2022 and 2027, and the growth momentum will [...]

M2 PRESSWIRE-October 25, 2023-: DelveInsight Unveils Comprehensive 2032 Analysis of Graves' Ophthalmopathy Market and Epidemiology: Treatment Market, Pipeline Drugs, FDA Approvals, and Leading Companies (C)1994-2023 M2 COMMUNICATIONS RDATE:25102023 (New York, [...]

(GlobeNewswire) - The 'Glycopeptide Antibiotics Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics market is set to witness substantial growth, with projections indicating [...]

NEW YORK: Technavio has issued the following news release: The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of [...]

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- The https://www.technavio.com/report/biosimilars-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t47_report_wk43_2023_014_IP&utm_content=IRTNTR70710 size is forecast to grow byUSD 42.22 billion between 2022 and 2027, and the growth momentum will be accelerating at aCAGR [...]

M2 PRESSWIRE-October 20, 2023-: Aortic Stenosis Market to Rise by 2032 | Boston Scientific Corporation, Medtronic plc, Novartis, Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, Edwards Lifesciences (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-October 20, 2023-: Acute Kidney Injury Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, AbbVie, Alloksys, Guard Therapeutics, Ocelot Bio (C)1994-2023 [...]

M2 PRESSWIRE-October 18, 2023-: Seasonal Influenza Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Cidara, Moderna, SAB Therapeutics, Sinovac Biotech, Novartis (C)1994-2023 M2 [...]

M2 PRESSWIRE-October 18, 2023-: Gastrointestinal Stromal Tumor Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Novartis, Cogent Biosciences, Plexxikon, Ariad Pharma, Exelixis (C)1994-2023 M2 [...]

M2 PRESSWIRE-October 17, 2023-: Advancements in the Complicated Urinary Tract Infection Market by 2032 - Insights from DelveInsight on Meiji Seika Pharma, Pfizer, Novartis, Spero Therapeutics, Tetraphase Pharmaceuticals, Wockhart (C)1994-2023 [...]

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/atopic-dermatitis-drugs-market-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week42_018_rep&utm_content=IRTNTR75242 size is expected to grow byUSD 4.7 billion from 2022 to 2027. In addition, the momentum of the market will be progressing [...]

M2 PRESSWIRE-October 16, 2023-: Portal Hypertension Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Boehringer Ingelheim, Gilead Sciences, Novartis, Cumberland Pharma, Conatus (C)1994-2023 M2 [...]

M2 PRESSWIRE-October 16, 2023-: Gastrointestinal Stromal Tumor Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Novartis, Taiho Pharma, Cogent Biosciences, Inc., Plexxikon, Ariad (C)1994-2023 M2 [...]

Dublin: Research and Markets has issued the following press release: The 'Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of [...]

DUBLIN, Oct. 13, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/report/ankylosing-spondylitis?utm_source=CI&utm_medium=PressRelease&utm_code=h8w49q&utm_campaign=1898475+-+Growing+Geriatric+Population+Fuels+Ankylosing+Spondylitis+Market%3a+Management+of+Pain+and+Mobility+Gains+Importance+in+Aging+Demographics&utm_exec=jamu273prd report has been added toResearchAndMarkets.com's offering. The global ankylosing spondylitis market is on a growth trajectory, with projections indicating an increase from [...]

NEW YORK, Oct. 12, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/respiratory-drugs-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t_2023_vrd_wk41_2023_020_rep&utm_content=IRTNTR73197 size is expected to grow byUSD 30.23 billion from 2022 to 2027. In addition, the momentum of the market will be progressing [...]

M2 PRESSWIRE-October 12, 2023-: Recurrent/Metastatic Nasopharyngeal Carcinoma Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Akesobio Inc., Novartis, Viracta Therapeutics, Coherus (C)1994-2023 M2 COMMUNICATIONS [...]

NEW YORK, Oct. 11, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/topical-corticosteroids-market-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t2023vrd_wk41_2023_016_rep&utm_content=IRTNTR75330 size is expected to grow byUSD 1.09 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

M2 PRESSWIRE-October 11, 2023-: Neurofibromatosis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Fosun Pharmaceutical, SpringWorks Therapeutics, NFlection Therapeutics, Inc (C)1994-2023 M2 COMMUNICATIONS RDATE:11102023 DelveInsight's [...]

M2 PRESSWIRE-October 10, 2023-: Central Nervous System Lymphoma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, Incyte, AstraZeneca, Roche, Cellectar Biosciences (C)1994-2023 [...]

M2 PRESSWIRE-October 10, 2023-: Non-radiographic Axial Spondyloarthritis (Nr-AxSpA) Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | UCB Biopharma, Novartis, Jiangsu HengRui (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-October 9, 2023-: Retinal Vein Occlusion Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Novartis, Allergan, Eyetech Pharma, Aerpio Therapeutics, Emmes (C)1994-2023 M2 [...]

(GLOBE NEWSWIRE via COMTEX) -- Ad hoc announcement pursuant to Art. 53 LR - Novartis executes separation of the Sandoz business to create an independent company by way of a [...]

NEW YORK, Oct. 4, 2023 /PRNewswire/ -- The https://www.technavio.com/report/cell-therapy-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t2023_vrd_wk40_2023_021_rep&utm_content=IRTNTR72148 size is expected to grow byUSD 31.04 billion from 2022 to 2027. In addition, the momentum of the market will progress [...]

The Growth of the small-cell lung cancer market is expected to be driven by increasing incident cases of SCLC, mainly due to an increase in the geriatric population, the expected [...]

European shares traded mixed on Tuesday due to concerns about rising bond yields and the US's avoiding a government shutdown. ArcelorMittal could report a sequential decline in numbers in the [...]

M2 PRESSWIRE-October 2, 2023-: Desmoid Tumors Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Pfizer, Novartis, SpringWorks Therapeutics, Ayala Pharmaceuticals, Iterion (C)1994-2023 M2 [...]